Role of testosterone in the treatment of hypoactive sexual desire disorder

Maturitas

Volumn 63, Issue 2, 2009, Pages 152-159

  Schwenkhagen, Anneliese ^a   Studd, John ^b  

^a Gynaekologicum Hamburg   (Germany)

^b London PMS and Menopause Centre   (United Kingdom)

Author keywords

Androgens; Hypoactive sexual desire disorder; Libido; Menopause; Testosterone

Indexed keywords

CONJUGATED ESTROGEN; ESTROGEN; PLACEBO; TESTOSTERONE;

ACNE; ANDROGEN DEFICIENCY; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DRUG DOSE COMPARISON; DRUG SAFETY; FEMALE; FEMALE SEXUAL DYSFUNCTION; HIRSUTISM; HORMONE ACTION; HUMAN; HYPOACTIVE SEXUAL DESIRE DISORDER; HYSTERECTOMY; LOW DRUG DOSE; MENOPAUSE; OVARIECTOMY; POSTOPERATIVE COMPLICATION; PREMENOPAUSE; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; REVIEW; SEXUAL BEHAVIOR; SEXUAL FUNCTION; SEXUAL SATISFACTION; TREATMENT RESPONSE;

FEMALE; HUMANS; MENOPAUSE; PREMENOPAUSE; SEXUAL DYSFUNCTION, PHYSIOLOGICAL; SEXUAL DYSFUNCTIONS, PSYCHOLOGICAL; SEXUALITY; TESTOSTERONE;

EID: 66949145237     PISSN: 03785122     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.maturitas.2009.02.011     Document Type: Review

References (53)

1. Shorr E., Papanicolaou G.N., and Stimmel B.F. Neutralization of ovarian follicular hormone in women by simultaneous administration of male sex hormone. Proc Soc Exp Bio Med 38 (1938) 759-762
2. Greenblatt R.B., Barfield W.E., Garner J.F., Calk G.L., and Harrod Jr. J.P. Evaluation of an estrogen, androgen, estrogen-androgen combination, and a placebo in the treatment of the menopause. J Clin Endocrinol Metab 10 (1950) 1547-1558
3. Glass S.J. The advantages of combined estrogen-androgen therapy of the menopause. J Clin Endocrinol Metab 10 (1950) 1616-1617
4. Birnberg C.H., and Kurzrock R. Low-dosage androgen-estrogen therapy in the older age group. J Am Geriatr Soc 3 (1955) 656-666
5. Burger H.G., Hailes J., Menelaus M., Nelson J., Hudson B., and Balazs N. The management of persistent menopausal symptoms with oestradiol-testosterone implants: clinical, lipid and hormonal results. Maturitas 6 (1984) 351-358
6. Sherwin B.B., and Gelfand M.M. The role of androgen in the maintenance of sexual functioning in oophorectomized women. Psychosom Med 49 (1987) 397-409
7. Davis S., McCloud P., Strauss B., and Burger H. Testosterone enhances estradiol's effects on postmenopausal bone density and sexuality. Maturitas 21 (1996) 227-236
8. Somboonporn W., Davis S., Seif M.W., and Bell R. Testosterone for peri- and postmenopausal women. Cochrane Database Syst Rev 4 (2005) 10.1002/14651858.CD004509.pub2 Art. No.: CD004509
9. Bachmann G., Bancroft J., Braunstein G., et al. Female androgen insufficiency: the Princeton consensus statement on definition, classification, and assessment. Fertil Steril 77 (2002) 660-665
10. Davison S.L., Bell R., Donath S., Montalto J.G., and Davis S.R. Androgen levels in adult females: changes with age, menopause, and oophorectomy. J Clin Endocrinol Metab 90 (2005) 3847-3853
11. Davison S.L., Bell R., Montalto J.G., et al. Measurement of total testosterone in women: comparison of a direct radioimmunoassay versus radioimmunoassay after organic solvent extraction and celite column partition chromatography. Fertil Steril 84 (2005) 1698-1704
12. Guay A., Munarriz R., Jacobson J., et al. Serum androgen levels in healthy premenopausal women with and without sexual dysfunction: Part A. Serum androgen levels in women aged 20-49 years with no complaints of sexual dysfunction. Int J Impot Res 16 (2004) 112-120
13. Labrie F., Bélanger A., Cusan L., Gomez J.L., and Candas B. Marked decline in serum concentrations of adrenal C19 sex steroid precursors and conjugated androgen metabolites during aging. J Clin Endocrinol Metab 82 (1997) 2396-2402
14. Zumoff B., Strain G.W., Miller L.K., and Rosner W. Twenty-four-hour mean plasma testosterone concentration declines with age in normal premenopausal women. J Clin Endocrinol Metab 80 (1995) 1429-1430
15. Burger H.G., Dudley E.C., Cui J., Dennerstein L., and Hopper J.L. A prospective longitudinal study of serum testosterone, dehydroepiandrosterone sulfate, and sex hormone-binding globulin levels through the menopause transition. J Clin Endocrinol Metab 85 (2000) 2832-2838
16. Judd H.L., Lucas W.E., and Yen S.S.C. Effect of oophorectomy on circulating testosterone and androstenedione levels in patients with endometrial cancer. Am J Obstet Gynecol 118 (1974) 793-798
17. Laughlin G.A., Barrett-Connor E., Kritz-Silverstein D., and von Mühlen D. Hysterectomy, oophorectomy, and endogenous sex hormone levels in older women: the Rancho Bernardo Study. J Clin Endocrinol Metab 85 (2000) 645-651
18. Fogle R.H., Stanczyk F.Z., Zhang X., and Paulson R.J. Ovarian androgen production in postmenopausal women. J Clin Endocrinol Metab 92 (2007) 3040-3043
19. Simon J.A. Estrogen replacement therapy: effects on the endogenous androgen milieu. Fertil Steril 77 Suppl. 4 (2002) S77-S82
20. Turna B., Apaydin E., Semerci B., Altay B., Cikili N., and Nazli O. Women with low libido: correlation of decreased androgen levels with female sexual function index. Int J Impot Res 17 (2005) 148-153
21. Guay A., Jacobson J., Munarriz R., et al. Serum androgen levels in healthy premenopausal women with and without sexual dysfunction: Part B. Reduced serum androgen levels in healthy premenopausal women with complaints of sexual dysfunction. Int J Impot Res 16 (2004) 121-129
22. Santoro N., Torrens J., Crawford S., et al. Correlates of circulating androgens in mid-life women: the study of women's health across the nation. J Clin Endocrinol Metab 90 (2005) 4836-4845
23. Davis S.R., Davison S.L., Donath S., and Bell R.J. Circulating androgen levels and self-reported sexual function in women. JAMA 294 (2005) 91-96
24. Labrie F., Luu-The V., Bélanger A., et al. Is dehydroepiandrosterone a hormone?. J Endocrinol 187 (2005) 169-196
25. Buster J.E., Kingsberg S.A., Aguirre O., et al. Testosterone patch for low sexual desire in surgically menopausal women: a randomized trial. Obstet Gynecol 105 (2005) 944-952
26. Simon J., Braunstein G., Nachtigall L., et al. Testosterone patch increases sexual activity and desire in surgically menopausal women with hypoactive sexual desire disorder. J Clin Endocrinol Metab 90 (2005) 5226-5233
27. Shifren J.L., Davis S.R., Moreau M., et al. Testosterone patch for the treatment of hypoactive sexual desire disorder in naturally menopausal women: results from the INTIMATE NM1 Study. Menopause 13 (2006) 770-779
28. Rhodes J.C., Kjerulff K.H., Langenberg P.W., and Guzinski G.M. Hysterectomy and sexual functioning. JAMA 282 (1999) 1934-1941
29. Nathorst-Boos J., and von Schoultz B. Psychological reactions and sexual life after hysterectomy with and without oophorectomy. Gynecol Obstet Invest 34 (1992) 97-101
30. Nathorst-Boos J., von Schoultz B., and Carlstrom K. Elective ovarian removal and estrogen replacement therapy-effects on sexual life, psychological wellbeing and androgen status. J Psychosom Obstet Gynaecol 14 (1993) 283-293
31. Dennerstein L., Koochaki P., Barton I., and Graziottin A. Hypoactive sexual desire disorder in menopausal women: a survey of Western European women. J Sex Med 3 (2006) 212-222
32. Hayes R.D., Dennerstein L., Bennett C.M., Koochaki P.E., Leiblum S.R., and Graziottin A. Relationship between hypoactive sexual desire disorder and aging. Fertil Steril 87 (2007) 107-112
33. Graziottin A. Prevalence and evaluation of sexual health problems-HSDD in Europe. J Sex Med 4 Suppl. 3 (2007) 211-219
34. Aziz A., Brännström M., Bergquist C., and Silfverstolpe G. Perimenopausal androgen decline after oophorectomy does not influence sexuality or psychological well-being. Fertil Steril 83 (2005) 1021-1028
35. Shifren J.L., Braunstein G.D., Simon J.A., et al. Transdermal testosterone treatment in women with impaired sexual function after oophorectomy. N Engl J Med 343 (2000) 682-688
36. Braunstein G.D., Sundwall D.A., Katz M., et al. Safety and efficacy of a testosterone patch for the treatment of hypoactive sexual desire disorder in surgically menopausal women: a randomized, placebo-controlled trial. Arch Intern Med 165 (2005) 1582-1589
37. Kingsberg S., Shifren J., Wekselman K., Rodenberg C., Koochaki P., and DeRogatis L. Evaluation of the clinical relevance of benefits associated with transdermal testosterone treatment in postmenopausal women with hypoactive sexual desire disorder. J Sex Med 4 (2007) 1001-1008
38. Davis S.R., van der Mooren M.J., van Lunsen R.H., et al. Efficacy and safety of a testosterone patch for the treatment of hypoactive sexual desire disorder in surgically menopausal women: a randomized, placebo-controlled trial. Menopause 13 (2006) 387-396
39. Davis S.R., Moreau M., Kroll R., et al. Testosterone for low libido in postmenopausal women not taking estrogen. N Engl J Med 359 (2008) 2005-2017
40. Goldstat R., Briganti E., Tran J., Wolfe R., and Davis S.R. Transdermal testosterone therapy improves well-being, mood, and sexual function in premenopausal women. Menopause 10 (2003) 390-398
41. Davis S., Papalia M.A., Norman R.J., et al. Safety and efficacy of a testosterone metered-dose transdermal spray for treating decreased sexual satisfaction in premenopausal women: a randomized trial. Ann Intern Med 148 (2008) 569-577
42. Braunstein G.D. Management of female sexual dysfunction in postmenopausal women by testosterone administration: safety issues and controversies. J Sex Med 4 (2007) 859-866
43. Hackenberg R., Hofmann J., Holzel F., and Schulz K.D. Stimulatory effects of androgen and antiandrogen on the in vitro proliferation of human mammary carcinoma cells. J Cancer Res Clin Oncol 114 (1988) 593-601
44. Marugo M., Bernasconi D., Miglietta L., et al. Effects of dihydrotestosterone and hydroxyflutamide on androgen receptors in cultured human breast cancer cells (EVSA-T). J Steroid Biochem Mol Biol 42 (1992) 547-554
45. Dimitrakakis C., Zhou J., Wang J., et al. A physiologic role for testosterone in limiting estrogenic stimulation of the breast. Menopause 10 (2003) 292-298
46. Ortmann J., Prifti S., Bohlmann M.K., Rehberger-Schneider S., Strowitzki T., and Rabe T. Testosterone and 5 alpha-dihydrotestosterone inhibit in vitro growth of human breast cancer cell lines. Gynecol Endocrinol 16 (2002) 113-120
47. Poulin R., Baker D., and Labrie F. Androgens inhibit basal and estrogen-induced cell proliferation in the ZR-75-1 human breast cancer cell line. Breast Cancer Res Treat 12 (1988) 213-225
48. Hofling M., Hirschberg A.L., Skoog L., Tani E., Hägerström T., and von Schoultz B. Testosterone inhibits estrogen/progestogen-induced breast cell proliferation in postmenopausal women. Menopause 14 (2007) 183-190
49. Hofling M., Löfgren L., von Schoultz E., Carlström K., and Söderqvist G. Associations between serum testosterone levels, cell proliferation and progesterone receptor content in normal and malignant breast tissue in postmenopausal women. Gynecol Endocrinol 24 (2008) 405-410
50. Bitzer J., Kenemans P., and Mueck A.O. Breast cancer risk in postmenopausal women using testosterone in combination with hormone replacement therapy. Maturitas 59 (2008) 209-218
51. Heard-Davison A., Heiman J.R., and Kuffel S. Genital and subjective measurement of the time course effects of an acute dose of testosterone vs. placebo in postmenopausal women. J Sex Med 4 (2007) 209-217
52. Chudakov B., Ben Zion I.Z., and Belmaker R.H. Transdermal testosterone gel prn application for hypoactive sexual desire disorder in premenopausal women: a controlled pilot study of the effects on the Arizona sexual experiences scale for females and sexual function questionnaire. J Sex Med 4 (2007) 204-208
53. El-Hage G., Eden J.A., and Manga R.Z. A double-blind, randomized, placebo-controlled trial of the effect of testosterone cream on the sexual motivation of menopausal hysterectomized women with hypoactive sexual desire disorder. Climacteric 10 (2007) 335-343